Sanara MedTech Inc (SMTI)
34.65
-1.35
(-3.75%)
USD |
NASDAQ |
Nov 15, 16:00
34.51
-0.14
(-0.40%)
After-Hours: 20:00
Sanara MedTech Research and Development Expense (TTM): 3.570M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.570M |
| March 31, 2024 | 3.761M |
| December 31, 2023 | 4.132M |
| September 30, 2023 | 4.515M |
| June 30, 2023 | 4.590M |
| March 31, 2023 | 4.480M |
| December 31, 2022 | 3.367M |
| September 30, 2022 | 2.634M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.608M |
| March 31, 2022 | 0.6451M |
| December 31, 2021 | 0.5587M |
| September 30, 2021 | 0.287M |
| June 30, 2021 | 0.2624M |
| March 31, 2021 | 0.1999M |
| December 31, 2020 | 0.0861M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.0861M
Minimum
Dec 2020
4.590M
Maximum
Jun 2023
2.313M
Average
2.634M
Median
Sep 2022
Research and Development Expense (TTM) Benchmarks
| AptarGroup Inc | -- |
| Daxor Corp | -- |
| Precision Optics Corp Inc | 0.9818M |
| Warby Parker Inc | -- |
| InfuSystems Holdings Inc | -- |